Unichem Laboratories Limited (BOM: 506690)
India
· Delayed Price · Currency is INR
894.70
+18.65 (2.13%)
At close: Nov 14, 2024
Unichem Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | -55.64 | -704.74 | -2,022 | 330.62 | 343.25 | -601.83 | Upgrade
|
Depreciation & Amortization | 1,118 | 1,132 | 1,134 | 911.05 | 815.06 | 795.79 | Upgrade
|
Other Amortization | 0.72 | 0.72 | 0.72 | 1.24 | 29.13 | 9.2 | Upgrade
|
Loss (Gain) From Sale of Assets | -48.89 | -48.59 | -12.83 | 2.34 | 5.23 | 18.57 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | 7.8 | Upgrade
|
Loss (Gain) From Sale of Investments | -693.82 | -712.32 | -40.27 | 17.49 | -116.42 | -273.53 | Upgrade
|
Loss (Gain) on Equity Investments | - | - | - | 10.61 | 3.43 | -8.13 | Upgrade
|
Stock-Based Compensation | 40.25 | 30.85 | 10.49 | 28.48 | 28.26 | 24.17 | Upgrade
|
Provision & Write-off of Bad Debts | 7.29 | 6.39 | 8.92 | -2.21 | 2.7 | -3.53 | Upgrade
|
Other Operating Activities | 1,466 | 1,489 | 364.23 | -351.47 | -83 | -306.1 | Upgrade
|
Change in Accounts Receivable | 438.47 | -163.83 | -1,236 | -2,771 | 950.82 | 630.94 | Upgrade
|
Change in Inventory | -1,999 | -794.47 | -250.08 | -618.82 | -1,418 | -578.76 | Upgrade
|
Change in Accounts Payable | 1,118 | -68.21 | 1,193 | -154.48 | -230.65 | 483.57 | Upgrade
|
Operating Cash Flow | 1,391 | 166.94 | -850.91 | -2,596 | 329.82 | 198.17 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | 66.44% | - | Upgrade
|
Capital Expenditures | -542.17 | -225.47 | -443.16 | -1,270 | -2,878 | -3,862 | Upgrade
|
Sale of Property, Plant & Equipment | 80.61 | 89.41 | 63.74 | 1.64 | 4.22 | 58.82 | Upgrade
|
Investment in Securities | 664.39 | 652.39 | 2,365 | 2,041 | 1,866 | 2,961 | Upgrade
|
Other Investing Activities | -75.38 | -12.28 | 42.45 | 251.49 | 272.22 | 482.09 | Upgrade
|
Investing Cash Flow | 127.44 | 504.04 | 2,028 | 1,024 | -735.58 | -359.12 | Upgrade
|
Short-Term Debt Issued | - | - | - | 1,148 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | 1,242 | - | - | Upgrade
|
Total Debt Issued | 617.1 | - | - | 2,390 | - | - | Upgrade
|
Short-Term Debt Repaid | - | -528.16 | -76.93 | - | -832.92 | -165.9 | Upgrade
|
Long-Term Debt Repaid | - | -310.6 | -290.63 | -143.65 | -47.87 | -47.06 | Upgrade
|
Total Debt Repaid | -746.56 | -838.76 | -367.56 | -143.65 | -880.8 | -212.96 | Upgrade
|
Net Debt Issued (Repaid) | -129.46 | -838.76 | -367.56 | 2,247 | -880.8 | -212.96 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 1.04 | Upgrade
|
Common Dividends Paid | -3.34 | -2.14 | -282.55 | -283.62 | -286.58 | -340.34 | Upgrade
|
Other Financing Activities | -184.91 | -222.21 | -162.9 | -50.82 | -43.37 | -70.73 | Upgrade
|
Financing Cash Flow | -317.71 | -1,063 | -813 | 1,912 | -1,211 | -623 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 45.63 | 63.73 | 381.33 | -22.78 | 75.92 | 1,129 | Upgrade
|
Net Cash Flow | 1,246 | -328.4 | 745.56 | 317.36 | -1,541 | 344.72 | Upgrade
|
Free Cash Flow | 848.87 | -58.53 | -1,294 | -3,866 | -2,548 | -3,663 | Upgrade
|
Free Cash Flow Margin | 4.79% | -0.34% | -9.64% | -30.45% | -20.63% | -33.19% | Upgrade
|
Free Cash Flow Per Share | 12.07 | -0.83 | -18.38 | -54.78 | -36.19 | -52.03 | Upgrade
|
Cash Interest Paid | 222.21 | 222.21 | 162.9 | 50.82 | 43.37 | 70.73 | Upgrade
|
Cash Income Tax Paid | 63.81 | 63.81 | 122.11 | 76.15 | 143.63 | 43.38 | Upgrade
|
Levered Free Cash Flow | 1,654 | 551.84 | -740.49 | -3,495 | -2,040 | -3,080 | Upgrade
|
Unlevered Free Cash Flow | 1,770 | 690.31 | -638.92 | -3,463 | -2,013 | -3,036 | Upgrade
|
Change in Net Working Capital | -842.89 | 166.27 | 368.3 | 3,066 | 52.75 | -810.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.